Cell therapy
Capricor develops cell-based medicines for Duchenne muscular dystrophy and other serious muscle and heart conditions. Its work centers on engineered cells and related biologic treatments that are tested in clinical trial...
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Capricor Therapeutics is a biotechnology company that develops cell-based medicines for serious diseases, with a main focus on heart and muscle disorders. Its lead program is deramiocel, an allogeneic cardiosphere-derived cell therapy being studied for Duchenne muscular dystrophy, a genetic disease that weakens muscles over time. The company also works on exosome-based therapies, which use tiny particles released by cells as a way to deliver treatment signals.
The company does not sell a broad range of drugs. It earns money mainly through research and development funding, collaboration payments, and, if its programs succeed, potential future product sales or licensing deals. Its main customers are not typical consumers; they are regulators, research partners, doctors, hospitals, and eventually patients and payers if a therapy reaches the market.
What makes Capricor different is that it sits very early in the drug-development chain and focuses on hard-to-treat rare diseases where standard medicines often do not help enough. Instead of making mass-market pills, it is building specialized biologic treatments that must be tested, approved, and then delivered through clinical and medical channels.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
New to Alpha Spread? Create free account
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Already have an account? Sign in
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more